In fact, the capacity of the EFNB2 ligand to increase the potential for growth, tumourigenicity and metastasis in many of these tumour cells is becoming increasingly apparent (Noren et al. 2004; Takai et al. 2001; Vogt et al. 1998). This evidence concerns the gene EFNB2 and neoplasm.